URGN News and Press, UroGen Pharma Ltd. From 03/14/24

2024-03-14 08:26:50 ET More on UroGen Pharma Urogen: Binary Bet On UGN-102 UroGen falls as Teva seeks FDA nod for Jelmyto generic Seeking Alpha’s Quant Rating on UroGen Pharma Read the full article on Seeking Alpha For further details see: ...

Initiated submission of a rolling NDA to the FDA for UGN-102; 12-month duration of response data from ENVISION expected to support completion of NDA submission Announced next-generation novel mitomycin-based RTGel formulations for LG-IR-NMIBC and LG-UTUC programs from medac GmbH licensing...

AIA Group Limited ADR (AAGIY) is expected to report for Q4 2023 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 SecureWorks Corp. (SCWX) is expected to report $-0.15 for Q4 2024 Acacia Research Corporation (ACTG) is expected to report for quarter end...

2024-03-13 11:07:29 ET More on UroGen Pharma Urogen: Binary Bet On UGN-102 UroGen falls as Teva seeks FDA nod for Jelmyto generic Seeking Alpha’s Quant Rating on UroGen Pharma Historical earnings data for UroGen Pharma Financial information for...

2024-03-13 10:29:03 ET Major earnings expected before the bell on Thursday include: Canadian Solar ( CSIQ ) Dollar General ( DG ) DICK'S Sporting Goods ( DKS ) Futu Holdings ( FUTU ) Hello Group ( MOMO ) Read the full article on Seeking Alph...

2024-03-10 13:08:00 ET More on ALX Oncology, Bicycle Therapeutics, etc. Immunocore Holdings plc (IMCR) Q4 2023 Earnings Call Transcript Kura Oncology, Inc. (KURA) Q4 2023 Earnings Call Transcript Kura Oncology, Inc. 2023 Q4 - Results - Earnings Call Presentation ...

2024-03-05 19:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Conference Call and Webcast Scheduled for Thursday, March 14, 2024, at 10:00 AM ET UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will report fourt...

- Presentation March 4, 2024 at 1:30 PM ET - UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will present at TD Cowen’s 44 th Annual Heal...

2024-02-24 05:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...